Background: The term sundowning is used to describe the emergence or worsening of neuropsychiatric symptoms in late afternoon or early evening in people with dementia. Objective: Our aim was to evaluate sundowning's prevalence and clinical manifestations among patients attending a tertiary memory clinic and to investigate its clinical and neuropsychological correlates. Methods: Patients with dementia attending our memory clinic were enrolled in the study. Sundowning was identified through a specifically designed questionnaire. Sociodemographic and clinical features of sundowners and non-sundowners were compared, and a logistic regression was performed to identify the variables associated with the phenomenon. A subgroup of patients underwent a complete neuropsychological assessment. Results: Among 184 recruited patients, 39 (21.2%) exhibited sundowning, mostly expressed as agitation (56.4%), irritability (53.8%), and anxiety (46.2%). Sundowners were significantly older, had a later dementia onset, exhibited more severe cognitive and functional impairment, more frequent nocturnal awakenings, and hearing loss relative to non-sundowners. They were also more likely to use anticholinergic medications and antipsychotics, and less likely to use memantine. In a multi-adjusted model, the factors significantly associated with sundowning were the Clinical Dementia Rating score (OR 3.88; 95% CI 1.39-10.90) and the use of memantine (OR 0.20; 95% CI 0.05-0.74). Participants with and without sundowning obtained similar results in single domain neuropsychological tests. Conclusion: Sundowning is commonly experienced by patients with dementia and appears as a multiply determined condition. Its presence should always be evaluated in clinical practice and a multidimensional approach should be adopted to identify its predictors.

Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates / Toccaceli Blasi, M.; Valletta, M.; Trebbastoni, A.; D'Antonio, F.; Talarico, G.; Campanelli, A.; Sepe Monti, M.; Salati, E.; Gasparini, M.; Buscarnera, S.; Salzillo, M.; Canevelli, M.; Bruno, G.. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 94:2(2023), pp. 601-610. [10.3233/JAD-230094]

Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates

Toccaceli Blasi M.;Valletta M.;Trebbastoni A.;D'Antonio F.;Talarico G.;Campanelli A.;Sepe Monti M.;Salati E.;Gasparini M.;Buscarnera S.;Salzillo M.;Canevelli M.;Bruno G.
2023

Abstract

Background: The term sundowning is used to describe the emergence or worsening of neuropsychiatric symptoms in late afternoon or early evening in people with dementia. Objective: Our aim was to evaluate sundowning's prevalence and clinical manifestations among patients attending a tertiary memory clinic and to investigate its clinical and neuropsychological correlates. Methods: Patients with dementia attending our memory clinic were enrolled in the study. Sundowning was identified through a specifically designed questionnaire. Sociodemographic and clinical features of sundowners and non-sundowners were compared, and a logistic regression was performed to identify the variables associated with the phenomenon. A subgroup of patients underwent a complete neuropsychological assessment. Results: Among 184 recruited patients, 39 (21.2%) exhibited sundowning, mostly expressed as agitation (56.4%), irritability (53.8%), and anxiety (46.2%). Sundowners were significantly older, had a later dementia onset, exhibited more severe cognitive and functional impairment, more frequent nocturnal awakenings, and hearing loss relative to non-sundowners. They were also more likely to use anticholinergic medications and antipsychotics, and less likely to use memantine. In a multi-adjusted model, the factors significantly associated with sundowning were the Clinical Dementia Rating score (OR 3.88; 95% CI 1.39-10.90) and the use of memantine (OR 0.20; 95% CI 0.05-0.74). Participants with and without sundowning obtained similar results in single domain neuropsychological tests. Conclusion: Sundowning is commonly experienced by patients with dementia and appears as a multiply determined condition. Its presence should always be evaluated in clinical practice and a multidimensional approach should be adopted to identify its predictors.
2023
Alzheimer's disease; dementia; neuropsychiatric symptoms; sundown syndrome; sundowning
01 Pubblicazione su rivista::01a Articolo in rivista
Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates / Toccaceli Blasi, M.; Valletta, M.; Trebbastoni, A.; D'Antonio, F.; Talarico, G.; Campanelli, A.; Sepe Monti, M.; Salati, E.; Gasparini, M.; Buscarnera, S.; Salzillo, M.; Canevelli, M.; Bruno, G.. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 94:2(2023), pp. 601-610. [10.3233/JAD-230094]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1714448
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact